Recent studies (Sangam et al., 2023; Walters et al., 2023) have unveiled that the dysregulation of SOX17 expression in IPAH patients significantly contributes to the disruption of endothelial functional homeostasis, thereby playing a pivotal role in the initiation and progression of pulmonary hypertension. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.